Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000992988> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W2000992988 endingPage "6" @default.
- W2000992988 startingPage "180" @default.
- W2000992988 abstract "Nefazodone, a new phenylpiperazine antidepressant agent with serotonin type 2 antagonism and serotonin reuptake inhibition, was evaluated in two patient groups to determine its effectiveness in reducing the symptoms of premenstrual syndrome (PMS). The two studied groups were PMS patients with no coexisting major depression or dysthymia (N = 23) and PMS patients with current major depression or dysthymia, termed the premenstrual exacerbation group (N = 24). The two patient groups received open-label nefazodone for 8 weeks, with optional maintenance at the same dose for up to 1 year. The initial dose was 100 mg, titrated to 600 mg/day, on a twice-daily dosing schedule. Symptoms were assessed by the Hamilton Rating Scale for Depression and by Daily Symptom Ratings. Premenstrual symptoms improved significantly from pretreatment baseline values, with similar improvement for the PMS and premenstrual exacerbation groups. Significantly improvement occurred by the end of the first treated cycle (4 weeks of therapy), at an average dose of 245 (range, 100 to 400) mg, and was maintained thereafter. Nefazodone was well tolerated, side effects were often transient, and the most common were nausea and headache. Forty-seven of 54 patients completed 2 months of therapy, with a mean daily nefazodone dose of 319 mg at the 2-month point. A placebo-controlled study should be conducted to confirm and extend these promising preliminary findings." @default.
- W2000992988 created "2016-06-24" @default.
- W2000992988 creator A5006903600 @default.
- W2000992988 creator A5018185385 @default.
- W2000992988 creator A5019914550 @default.
- W2000992988 creator A5043180253 @default.
- W2000992988 creator A5051093813 @default.
- W2000992988 creator A5051177591 @default.
- W2000992988 date "1994-06-01" @default.
- W2000992988 modified "2023-09-23" @default.
- W2000992988 title "Nefazodone in the treatment of premenstrual syndrome: a preliminary study." @default.
- W2000992988 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8027414" @default.
- W2000992988 hasPublicationYear "1994" @default.
- W2000992988 type Work @default.
- W2000992988 sameAs 2000992988 @default.
- W2000992988 citedByCount "25" @default.
- W2000992988 countsByYear W20009929882019 @default.
- W2000992988 crossrefType "journal-article" @default.
- W2000992988 hasAuthorship W2000992988A5006903600 @default.
- W2000992988 hasAuthorship W2000992988A5018185385 @default.
- W2000992988 hasAuthorship W2000992988A5019914550 @default.
- W2000992988 hasAuthorship W2000992988A5043180253 @default.
- W2000992988 hasAuthorship W2000992988A5051093813 @default.
- W2000992988 hasAuthorship W2000992988A5051177591 @default.
- W2000992988 hasConcept C118552586 @default.
- W2000992988 hasConcept C126322002 @default.
- W2000992988 hasConcept C139719470 @default.
- W2000992988 hasConcept C142724271 @default.
- W2000992988 hasConcept C15744967 @default.
- W2000992988 hasConcept C162324750 @default.
- W2000992988 hasConcept C170493617 @default.
- W2000992988 hasConcept C204787440 @default.
- W2000992988 hasConcept C27081682 @default.
- W2000992988 hasConcept C2775864247 @default.
- W2000992988 hasConcept C2776134451 @default.
- W2000992988 hasConcept C2776867660 @default.
- W2000992988 hasConcept C2777014857 @default.
- W2000992988 hasConcept C2777288759 @default.
- W2000992988 hasConcept C2779177272 @default.
- W2000992988 hasConcept C2779419675 @default.
- W2000992988 hasConcept C2780580376 @default.
- W2000992988 hasConcept C42219234 @default.
- W2000992988 hasConcept C558461103 @default.
- W2000992988 hasConcept C71924100 @default.
- W2000992988 hasConceptScore W2000992988C118552586 @default.
- W2000992988 hasConceptScore W2000992988C126322002 @default.
- W2000992988 hasConceptScore W2000992988C139719470 @default.
- W2000992988 hasConceptScore W2000992988C142724271 @default.
- W2000992988 hasConceptScore W2000992988C15744967 @default.
- W2000992988 hasConceptScore W2000992988C162324750 @default.
- W2000992988 hasConceptScore W2000992988C170493617 @default.
- W2000992988 hasConceptScore W2000992988C204787440 @default.
- W2000992988 hasConceptScore W2000992988C27081682 @default.
- W2000992988 hasConceptScore W2000992988C2775864247 @default.
- W2000992988 hasConceptScore W2000992988C2776134451 @default.
- W2000992988 hasConceptScore W2000992988C2776867660 @default.
- W2000992988 hasConceptScore W2000992988C2777014857 @default.
- W2000992988 hasConceptScore W2000992988C2777288759 @default.
- W2000992988 hasConceptScore W2000992988C2779177272 @default.
- W2000992988 hasConceptScore W2000992988C2779419675 @default.
- W2000992988 hasConceptScore W2000992988C2780580376 @default.
- W2000992988 hasConceptScore W2000992988C42219234 @default.
- W2000992988 hasConceptScore W2000992988C558461103 @default.
- W2000992988 hasConceptScore W2000992988C71924100 @default.
- W2000992988 hasIssue "3" @default.
- W2000992988 hasLocation W20009929881 @default.
- W2000992988 hasOpenAccess W2000992988 @default.
- W2000992988 hasPrimaryLocation W20009929881 @default.
- W2000992988 hasRelatedWork W16404938 @default.
- W2000992988 hasRelatedWork W1915433549 @default.
- W2000992988 hasRelatedWork W1982931338 @default.
- W2000992988 hasRelatedWork W2046801408 @default.
- W2000992988 hasRelatedWork W2070384222 @default.
- W2000992988 hasRelatedWork W2091962952 @default.
- W2000992988 hasRelatedWork W2321944344 @default.
- W2000992988 hasRelatedWork W2409011936 @default.
- W2000992988 hasRelatedWork W2409616553 @default.
- W2000992988 hasRelatedWork W282266550 @default.
- W2000992988 hasVolume "14" @default.
- W2000992988 isParatext "false" @default.
- W2000992988 isRetracted "false" @default.
- W2000992988 magId "2000992988" @default.
- W2000992988 workType "article" @default.